top of page

威利奖学金申请

HIo8mifa0AAhbnp.jpeg

2025年威利学者奖申请现已开放。有关奖项和申请提交的问题,请发送邮件至grants@vascularcures.org 。申请截止日期为2025年4月1日。


2025年“血管疾病治疗促进基金会”设立的“威利学者奖”是一项为期一年、奖金为5万美元的资助项目,旨在支持杰出的青年血管外科医生科学家,鼓励他们将临床实践与原创性创新研究相结合,投身学术研究。该奖项可续期一年。基金会致力于通过培养下一代顶尖血管外科医生科学家来推动该领域的发展,并期望该奖项能够帮助获奖者在其职业生涯早期开展具有影响力的血管研究,从而帮助他们获得国家卫生机构以及其他州和基金会的独立资助。2025年“威利学者奖”的获得者将有机会与一位往届“威利学者奖”获得者结对,后者将担任其导师/顾问,并为其研究项目提供指导。

奖励用途

该奖项可用于支持以下领域的研究:

基础科学、转化医学、临床研究、以患者为中心的研究、结果/卫生服务研究、教学、社区服务和患者护理。请注意,血管疾病治疗促进基金会不支付间接费用。

合格

The Foundation intends to fund up to two pilot projects, not to exceed $75,000 and a project duration of up to 15 months. Awards may be made in categories 2(a) and/or 2(b).

 

2(a) Frederick M. Binkley Research Award
The Frederick M. Binkley Research Award honors the legacy of Dr. Frederick M. “Ted” Binkley, a pioneer in vascular surgery whose career was defined by excellence in science and patient care, and a commitment to collaboration.

 

The Award supports collaborative, patient-informed pilot research projects that address critical gaps in vascular health and have the potential to advance vascular science and improve patient outcomes. The goal is to fund projects at early stages of development and to encourage innovative approaches, readying these for larger scale clinical trials and/or other research studies.

 

Examples include:
● Mechanisms by which GLP-1 receptor agonists improve vascular outcomes.
● Biomarkers of wound healing.
● Microvascular function assessment.
● Inflammatory biomarkers as surrogate measures.
● Precision medicine approaches for PAD and CLTI.
● Clinical phenotyping, including calcific versus lipid-rich disease.
● Hormonal replacement therapy and vascular disease.
● Clinical decision support tools incorporating biomarker data.

● Leveraging existing databases and clinical datasets to generate novel mechanistic insights.

 

2(b) Collaborative Patient-Centered Research Award
The Collaborative Patient-Centered Research Award supports innovative pilot projects
designed to improve patient engagement, trust, education, implementation of
evidence-based therapies, health literacy, adherence, community engagement, and
participation in research.

 

Projects submitted under this award mechanism must demonstrate a clear connection to
the metabolic-vascular relationship and address how enhanced patient engagement,
education, or trust may improve outcomes among patients with PAD, CLTI, or other
vascular conditions influenced by metabolic dysfunction.

 

Examples include:
● Measuring and building trust in healthcare and science.
● Educational interventions that improve disease awareness and health literacy.
● Best practices for educational programs supporting clinical care or research
participation.
● Development of patient-facing educational tools and instructional videos.
● Leveraging nurse educators, pharmacists, patients, caregivers, and community
health workers.
● Addressing misinformation and improving adherence to medical therapy.
● Community-based approaches that improve cultural competency and
engagement.
● Strategies to improve participation in clinical trials and research programs.
Applicants should indicate which award mechanism for which they are applying.

奖励用途

该奖项可用于支持以下领域的研究:

基础科学、转化医学、临床研究、以患者为中心的研究、结果/卫生服务研究、教学、社区服务和患者护理。请注意,血管疾病治疗促进基金会不支付间接费用。

合格

Proposals may not exceed five pages, single spaced, 11-point font, excluding supplemental appendices (maximum four pages).

 

Applications should include:
1. Key unmet need addressed by the proposal
2. Project goals and specific aims
3. Innovation
4. Milestones and deliverables
5. Research strategy and methods
6. Shared resources and how they will be used or developed
7. Impact of project results and future directions
8. Investigator Documentation:
● NIH/AHRQ Biographical Sketch Common Form or NIH Biographical Sketch Supplement (Current and Pending (Other) Support Common Form)
● Description of investigator roles and contributions
9. Budget and budget worksheet, including budgets by milestone and collaborator

 

Applicants are responsible for ensuring that all investigator documentation conforms to
NIH Common Forms requirements in effect at the time of submission.

奖励用途

该奖项可用于支持以下领域的研究:

基础科学、转化医学、临床研究、以患者为中心的研究、结果/卫生服务研究、教学、社区服务和患者护理。请注意,血管疾病治疗促进基金会不支付间接费用。

合格

All researchers are invited to apply.


Proposals that do not include collaboration between two or more institutions will not be considered. Priority will be given to proposals led or co-led by attendees of the 2026 Vascular Health Innovation Summit (held on May 18, 2026 in San Francisco) when applications receive similar review scores.

联系我们了解更多信息

红木海岸大道274号717室
加利福尼亚州红木城,邮编 94065
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

血管治疗媒体

  • Instagram

冠军社交媒体

Foundation+to+Advance+Cures_National+Health+Information+Award.webp

血管疾病治疗促进基金会是一个免税的非营利组织,税务识别号为:94-2825216,符合美国国税法典第501(c)(3)条的规定。捐款可享受税收减免。
版权所有 © 2024 血管疾病治疗促进基金会。保留所有权利。

bottom of page